🍬𝐒𝐰𝐞𝐞𝐭 𝐂𝐡𝐫𝐢𝐬𝐭𝐦𝐚𝐬 𝐚𝐧𝐝 𝐚 𝐇𝐚𝐩𝐩𝐲 𝐇𝐨𝐥𝐢𝐝𝐚𝐲𝐬 𝐟𝐫𝐨𝐦 𝐆𝐥𝐲𝐜𝐚𝐧𝐓𝐫𝐢𝐠𝐠𝐞𝐫! 🎄 As we wrap up an incredible year, we want to take a moment to thank our amazing community for your continued support and engagement. May this festive season bring you joy, peace, and all the warmth of the holiday spirit ❤️ Wishing you a wonderful Christmas filled with love, laughter, and special moments with your loved ones. Here is to new beginnings and exciting opportunities in the year ahead! 🌟 Enjoy the festivities and we will see you in 2025! 🎅🤶🎉 #GlycanTrigger #glycans #IBD #HorizonEurope
About us
Horizon Europe funded project 🚀 The project aims to investigate how changes in the sugar chains (glycans) found on the surface of the gut mucosa (the gut glycome) can cause inflammation in the digestive system!
- Website
-
https://glycantrigger.eu/
External link for GlycanTrigger EU Project
- Industry
- Public Health
- Company size
- 11-50 employees
- Type
- Nonprofit
Updates
-
Check your inbox 📩—our fourth newsletter edition has just launched! 🚀 This issue is packed with updates and insights, including: ✨ Highlights from the 1st GlycanTrigger Patients Symposium 🎙️ The release of our second podcast episode 📌 Key milestones and project updates 💻 Read the latest newsletter here: https://lnkd.in/da_M9B66 👉 Don’t miss out! Subscribe on our website (www.glycantrigger.eu) or click here: http://eepurl.com/it4FfM #GlycanTrigger #IBD #glycotime #CrohnsDisease #UlcerativeColitis #Glycans #HorizonEurope
-
💜 𝐈𝐭'𝐬 𝐂𝐫𝐨𝐡𝐧'𝐬 & 𝐂𝐨𝐥𝐢𝐭𝐢𝐬 𝐀𝐰𝐚𝐫𝐞𝐧𝐞𝐬𝐬 𝐖𝐞𝐞𝐤! 💜 From December 1–7, we come together to raise awareness about Crohn’s disease and ulcerative colitis—inflammatory bowel diseases (IBD) that affect millions worldwide 🌍 Characterized by chronic inflammation of the digestive tract, these diseases can lead to symptoms like abdominal pain, cramping, severe fatigue, and diarrhea. 𝐖𝐡𝐚𝐭 𝐢𝐬 𝐂𝐫𝐨𝐡𝐧'𝐬 𝐚𝐧𝐝 𝐂𝐨𝐥𝐢𝐭𝐢𝐬 𝐀𝐰𝐚𝐫𝐞𝐧𝐞𝐬𝐬 𝐖𝐞𝐞𝐤? Occurring annually, this week is dedicated to increasing understanding and support for those living with IBD. 💊 Aims to improve treatment, support patients & caregivers worldwide 🩺 Promotes understanding of symptoms, causes, and quality of life 🔬 Advocates for research, proper care, and effective management strategies Join the movement to raise awareness, compassion, and knowledge about these conditions. Together, we can make a difference! 💜 #GlycanTrigger #CrohnsAndColitisAwarenessWeek #PatientEmpowerment
-
𝗨𝗻𝗱𝗲𝗿𝘀𝘁𝗮𝗻𝗱𝗶𝗻𝗴 𝗜𝗕𝗗: 𝗕𝗿𝗶𝗱𝗴𝗶𝗻𝗴 𝗞𝗻𝗼𝘄𝗹𝗲𝗱𝗴𝗲 𝗧𝗼𝘄𝗮𝗿𝗱𝘀 𝗗𝗶𝘀𝗲𝗮𝘀𝗲 𝗣𝗿𝗲𝗱𝗶𝗰𝘁𝗶𝗼𝗻 𝗮𝗻𝗱 𝗣𝗿𝗲𝘃𝗲𝗻𝘁𝗶𝗼𝗻 – 𝟏𝟒𝘁𝗵 𝗘𝗱𝗶𝘁𝗶𝗼𝗻 Inflammatory bowel disease (IBD) is the name for a group of chronic conditions that affect the digestive tract. While there is no guaranteed way to prevent the development of IBD, there are some steps you can take to reduce your risk. Here are some tips: 🚭 𝐀𝐯𝐨𝐢𝐝 𝐭𝐨𝐛𝐚𝐜𝐜𝐨: Smoking has been linked to an increased risk of developing Crohn's disease, so avoiding tobacco is one way to reduce your risk. 🥗 𝐄𝐚𝐭 𝐚 𝐡𝐞𝐚𝐥𝐭𝐡𝐲 𝐝𝐢𝐞𝐭: A healthy diet that includes plenty of fruits, vegetables, and whole grains can help reduce inflammation and support digestive health. 🏃♀️ 𝐄𝐱𝐞𝐫𝐜𝐢𝐬𝐞 𝐫𝐞𝐠𝐮𝐥𝐚𝐫𝐥𝐲: Regular exercise has been linked to a reduced risk of IBD, possibly due to its anti-inflammatory effects. While these steps may not eliminate your risk of developing IBD, they can help support overall health and reduce the likelihood of developing other digestive conditions. As always, be sure to talk to your healthcare provider about any concerns you may have. 📚 The "Understanding IBD: Bridging Knowledge Towards Disease Prediction and Prevention" is an initiative led by the GlycanTrigger EU Project. It is dedicated to providing comprehensive, accurate, and easily understandable information about #IBD, #lifestylemanagement, and #patientempowerment. 👩🏻⚕️👨🏽⚕️ Let's bridge the gap between knowledge and well-being! 💪 #GlycanTrigger #Glycans #glycotime #IBD #Crohnsdisease #UlcerativeColitis #PatientEmpowerment #HorizonEurope
-
📅 Mark your calendars for the 2nd ENDOTARGET EU Project webinar on December 12th. The webinar will focus on the role of diet in arthritis within the framework of the ENDOTARGET EU Project. This session is a unique opportunity for patients, caregivers, healthcare professionals, and researchers to come together and explore this topic with speakers from the Gulbenkian Institute for Molecular Medicine in Lisbon, Portugal (formerly the Institute for Molecular Medicine, iMM). 🔍 Learn more about the ENDOTARGET EU Project and dive deeper into the following topics: • Understanding immune-mediated conditions in children • The interplay between diet and the gut-immune axis • Why diet matters in autoimmune research: The TASTY study • Early insights from the TASTY study Register to secure your spot and be a part of this important conversation 🔗 https://lnkd.in/eCwd8K-W i3S - Instituto de Investigação e Inovação em Saúde
🚨Webinar Alert 🚨 ❓ Have you always wanted to know more about the role of diet in arthritis? ❗ Then join us for the 2nd ENDOTARGET EU Project Webinar: 🌟 "A TASTY take on immunity: The role of Diet in Arthritis"!🌟 📅 Date: December 12, 2024 🕒 Time: 18:00 - 19:30 CET 💻 Location: Online 📢 Stay tuned for further updates on webinar topics and our unique speakers from the Gulbenkian Institute for Molecular Medicine, Lisbon! 🎟️ The webinar is FREE but registration is required. Don’t miss out! 🔗 https://lnkd.in/eCwd8K-W #ENDOTARGET #Webinar #Diet #RheumaticDiseases
-
🚨 Missed the 1st GlycanTrigger Patients Symposium yesterday? 🎥 You can watch the full event on Youtube: https://lnkd.in/g3GVACCh Catch inspiring stories, expert insights, and engaging discussions! 💡
📣 Yesterday, at the first GlycanTrigger Patients Symposium, we explored research showing that IBD can often be predicted years before diagnosis. This raises vital questions about understanding the sequence of events leading to the disease. By better framing the different stages of risk, we can work toward tailored preventive strategies—ones that could truly modify the disease course and outcomes. Imagine the impact of detecting IBD early, or even preventing it altogether! 🙌 Maria Cândida Cruz, Vice President of APDI - Associação Portuguesa da Doença Inflamatória do Intestino, Filipa Cunha, APDI board and EFCCA Youth Group, as well as Olivera Culibrk (Serbia) and Alexandra Roventa (Romania) shared personal and insightful perspectives on how an IBD diagnosis has impacted their lives and highlighted the importance of empowering people with IBD to navigate their journeys. Many other speakers provided great input and with around 50 patients and patient representatives in attendance, the symposium offered fascinating insights and plenty of food for thought. Collaborative efforts across research and healthcare are more crucial than ever to turn this knowledge into action. Let’s work together to shape a future where prevention is possible. 💡 💻 Watch the full symposium here: https://lnkd.in/g3GVACCh
-
🚨𝗪𝗲 𝗔𝗿𝗲 𝗟𝗶𝘃𝗲!🚨 The 1st GlycanTrigger Patients Symposium is now streaming live on YouTube! Join us as we explore into interesting discussions on Inflammatory Bowel Disease (IBD) prediction and prevention featuring the leading experts and Patient stories. 📺 Follow the live stream here: https://lnkd.in/g3GVACCh Stay tuned! Don't miss the opportunity to engage in this event! 💡 #GlycanTrigger #PatientsSymposium #IBD #HealthcareInnovation #LiveNow
1st GlycanTrigger Patients Symposium
https://www.youtube.com/
-
🚨 Last chance to register for the 𝟭𝘀𝘁 𝗚𝗹𝘆𝗰𝗮𝗻𝗧𝗿𝗶𝗴𝗴𝗲𝗿 𝗣𝗮𝘁𝗶𝗲𝗻𝘁𝘀 𝗦𝘆𝗺𝗽𝗼𝘀𝗶𝘂𝗺! 🗓️ Date: November 19th, 2024 🕒 Time: 5:30 - 7:00 PM CET (4:30 - 6:00 PM Lisbon time) 💻 Location: Zoom, Online Join us as we explore key risk factors, prevention strategies, and the vital role of patient involvement in managing chronic inflammatory bowel diseases (IBD). This is a great opportunity to engage with IBD experts, healthcare professionals, researchers, and patient associations 👀 Check out the sessions and speakers! ✍🏻 Register now to secure your spot: 👉 www.glycantrigger.eu Hospital da Luz Learning Health miGut-Health APDI - Associação Portuguesa da Doença Inflamatória do Intestino i3S - Instituto de Investigação e Inovação em Saúde European Federation of Crohn's and Ulcerative Colitis Associations SPI - Sociedade Portuguesa de Inovação
-
⏳ Only 4 days left until the 1st GlycanTrigger Patients Symposium! ⏳ Do not miss the opportunity to deepen your knowledge of the prevention and prediction of Inflammatory Bowel Disease. Check out the event agenda and join us! 🗓️ Date: November 19th, 2024 🕒 Time: 5:30 - 7:00 PM CET (4:30 - 6:00 PM Lisbon time) 💻 Location: Online (Webinar in English) 🎥 The event will be livestreamed on the GlycanTrigger YouTube Channel: https://lnkd.in/dPEJTYAU ✍🏻 Register at www.glycantrigger.eu
-
𝗦𝗮𝘃𝗲 𝘁𝗵𝗲 𝗗𝗮𝘁𝗲: 𝟭𝘀𝘁 𝗚𝗹𝘆𝗰𝗮𝗻𝗧𝗿𝗶𝗴𝗴𝗲𝗿 𝗣𝗮𝘁𝗶𝗲𝗻𝘁𝘀 𝗦𝘆𝗺𝗽𝗼𝘀𝗶𝘂𝗺 - 𝗡𝗼𝘃𝗲𝗺𝗯𝗲𝗿 𝟭𝟵𝘁𝗵, 𝟮𝟬𝟮𝟰 We are pleased to feature Maria Cândida Cruz from APDI - Associação Portuguesa da Doença Inflamatória do Intestino as a Speaker with her presentation, “Identifying Patient challenges in Inflammatory Bowel Diseases”. This insightful session will explore into the critical challenges faced by IBD patients throughout their treatment journey. The presentation will focus on key topics such as Improving Patient Education in where should we invest our efforts and the role to be displayed by Healthcare Professionals, doctor-nurse. ➡️ Join us on November 19th, don't miss the chance to gain valuable insights on enhancing patient care in the context of IBD. Be part of this relevant discussion aimed at predicting and preventing IBD while addressing the needs of patients. Further details about the Sessions and Speakers will be shared in the upcoming days. ⛓️💥 Stay tuned: 📅 Date: November 19th, 2024 🕒 Time: 5:30 - 7:00 PM CET (4:30 - 6:00 PM Lisbon time) 💻Location: Online (Webinar in English) Don’t miss out on this opportunity and register now to secure your spot 👉 Registration at: www.glycantrigger.eu #GlycanTrigger #Glycans #glycotime #Crohnsdisease #PatientCare #Healthcareprofessionals #PatientEducation #HorizonEurope